You are here

Article info

Article menu
Download PDFPDF
Letter
Plasma oxypurinol as a measure of adherence in clinical trials

Authors

  1. Correspondence to Professor Lisa Stamp, Department of Medicine, University of Otago, Christchurch, P. O. Box 4345 Christchurch 8140, New Zealand; lisa.stamp{at}cdhb.health.nz
View Full Text

Citation

Stamp LK, Merriman T, Frampton C, et al
Plasma oxypurinol as a measure of adherence in clinical trials
Annals of the Rheumatic Diseases 2018;77:313-314.

Publication history

  • Received October 9, 2016
  • Revised December 15, 2016
  • Accepted December 17, 2016
  • First published January 5, 2017.
Online issue publication 
April 20, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/